Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses

Transvaginal ultrasound and serum CA125 are routinely used for differential diagnosis of pelvic adnexal mass. Use of Human Epididymis 4 (HE4) was approved in the United States in 2011. However, there is scarcity of studies evaluating the additional value of HE4.

Source: American Journal of Obstetrics and Gynecology - July 23, 2019 Category: OBGYN Authors: Aleksandra Gentry-Maharaj, Matthew Burnell, James Dilley, Andy Ryan, Chloe Karpinskyj, Richard Gunu, Susan Mallett, Jon Deeks, Stuart Campbell, Ian Jacobs, Sudha Sundar, Usha Menon Tags: Original Research: Gynecology Source Type: research